{"id":"https://openalex.org/W1990677808","doi":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","display_name":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","publication_year":2012,"publication_date":"2012-02-14","ids":{"openalex":"https://openalex.org/W1990677808","doi":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","mag":"1990677808","pmid":"https://pubmed.ncbi.nlm.nih.gov/22332800"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2265.2012.04365.x","doi":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Fumiko Otsuka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]},{"id":"https://openalex.org/I4210156626","display_name":"SHOWA Medical University Fujigaoka Hospital","ror":"https://ror.org/0543mcr22","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210156626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Fumiko Otsuka","raw_affiliation_strings":["Division of Endocrinology and Metabolism Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama Japan","Ito Hospital Tokyo Japan","Showa University Fujigaoka Hospital Division of Endocrinology and Metabolism Yokohama Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama Japan","institution_ids":["https://openalex.org/I4210156626"]},{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]},{"raw_affiliation_string":"Showa University Fujigaoka Hospital Division of Endocrinology and Metabolism Yokohama Japan","institution_ids":["https://openalex.org/I4210156626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076464766","display_name":"Jaeduk Yoshimura Noh","orcid":"https://orcid.org/0000-0001-7340-8603","observed_orcids":["https://orcid.org/0000-0001-7340-8603"]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jaeduk Y. Noh","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063386012","display_name":"Toshiko Chino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiko Chino","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Taeko Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taeko Shimizu","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Koji Mukasa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koji Mukasa","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kunihiko Ito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kunihiko Ito","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028206707","display_name":"Koichi Ito","orcid":"https://orcid.org/0000-0002-2042-405X","observed_orcids":["https://orcid.org/0000-0002-2042-405X"]},"institutions":[{"id":"https://openalex.org/I4210105488","display_name":"Ito Hospital","ror":"https://ror.org/01pc3rk31","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Ito","raw_affiliation_strings":["Ito Hospital Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ito Hospital Tokyo Japan","institution_ids":["https://openalex.org/I4210105488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025888553","display_name":"Matsuo Taniyama","orcid":"https://orcid.org/0009-0003-7287-2297","observed_orcids":["https://orcid.org/0009-0003-7287-2297"]},"institutions":[{"id":"https://openalex.org/I4210156626","display_name":"SHOWA Medical University Fujigaoka Hospital","ror":"https://ror.org/0543mcr22","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210156626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Matsuo Taniyama","raw_affiliation_strings":["Division of Endocrinology and Metabolism, Department of Internal Medicine, Showa University, Fujigaoka Hospital, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Showa University, Fujigaoka Hospital, Yokohama, Japan","institution_ids":["https://openalex.org/I4210156626"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210105488","https://openalex.org/I4210156626"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":2.4714,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.88344229,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"77","issue":"2","first_page":"310","last_page":"315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.20360000431537628,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antithyroid-drugs","display_name":"antithyroid drugs","score":0.9789999723434448},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/skin-reactions","display_name":"skin reactions","score":0.8330000042915344},{"id":"https://openalex.org/keywords/graves-disease","display_name":"Graves' disease","score":0.8130000233650208},{"id":"https://openalex.org/keywords/methimazole","display_name":"methimazole","score":0.8889999985694885},{"id":"https://openalex.org/keywords/propylthiouracil","display_name":"propylthiouracil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9359999895095825},{"id":"https://openalex.org/keywords/drug-switching","display_name":"drug switching","score":0.6039999723434448},{"id":"https://openalex.org/keywords/drug-dosage","display_name":"drug dosing","score":0.4749999940395355},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.652999997138977},{"id":"https://openalex.org/keywords/drug-cross-reactivity","display_name":"drug cross-reactivity","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2775960720","wikidata":"https://www.wikidata.org/wiki/Q377342","display_name":"Propylthiouracil","level":3,"score":0.9310585260391235},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8108112215995789},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6713807582855225},{"id":"https://openalex.org/C2776606491","wikidata":"https://www.wikidata.org/wiki/Q1365501","display_name":"Antithyroid agent","level":4,"score":0.625135064125061},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.5394047498703003},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5320561528205872},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5151199698448181},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.416670560836792},{"id":"https://openalex.org/C2776652619","wikidata":"https://www.wikidata.org/wiki/Q16483","display_name":"Graves' disease","level":3,"score":0.3663995563983917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23790690302848816},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.22324207425117493},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.21372967958450317},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006111","descriptor_name":"Graves Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008713","descriptor_name":"Methimazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008713","descriptor_name":"Methimazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011441","descriptor_name":"Propylthiouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011441","descriptor_name":"Propylthiouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013956","descriptor_name":"Antithyroid Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013956","descriptor_name":"Antithyroid Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2265.2012.04365.x","doi":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2012.04365.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:22332800","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22332800","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Journal Article"},{"id":"mag:2395775435","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/500000935065","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W196555503","https://openalex.org/W1965108974","https://openalex.org/W1966962190","https://openalex.org/W2032059056","https://openalex.org/W2046713203","https://openalex.org/W2057760665","https://openalex.org/W2084763031","https://openalex.org/W2087168987","https://openalex.org/W2087256708","https://openalex.org/W2129829826","https://openalex.org/W2133201734","https://openalex.org/W2167716419","https://openalex.org/W2394585122","https://openalex.org/W2432809173","https://openalex.org/W3022564440"],"related_works":["https://openalex.org/W2363907362","https://openalex.org/W2784066515","https://openalex.org/W2419311994","https://openalex.org/W3032158039","https://openalex.org/W1482362129","https://openalex.org/W1497976777","https://openalex.org/W144732572","https://openalex.org/W2027386028","https://openalex.org/W113961078","https://openalex.org/W2032059056"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Use":[1],"of":[2,18,92,110,136,149,193,221,223,232,237,244],"the":[3,48,100,105,111,180,187,200,224,229],"antithyroid":[4],"drugs":[5],"(ATDs)":[6],"thiamazole":[7],"(MMI)":[8],"and":[9,35,50,83,90,119,158,202,235],"propylthiouracil":[10],"(PTU)":[11],"is":[12,32,37],"associated":[13,46,103],"with":[14,26,47,60,104,174],"a":[15,208],"high":[16],"frequency":[17,89,135,192,210],"side":[19,24,44,93,101,121,137,194,233],"effects.":[20],"When":[21],"patients":[22,59,140,153,212],"experience":[23],"effects":[25,45,94,102,122,138,195,234],"one":[27],"(the":[28,39],"1st)":[29],"ATD,":[30],"it":[31],"usually":[33],"discontinued":[34],"another":[36],"administered":[38],"2nd":[40,51,106,201],"ATD).":[41],"We":[42,97],"investigated":[43],"1st":[49,112,203],"ATDs.":[52,204],"DESIGN":[53],"AND":[54],"PATIENTS:":[55],"Four":[56],"hundred":[57],"forty-nine":[58],"untreated":[61],"Graves'":[62],"disease":[63],"(GD)":[64],"were":[65,95,123,166,214],"randomly":[66],"assigned":[67],"to":[68,72,218,228,241],"three":[69],"groups":[70],"according":[71],"ATD":[73,107,130],"type":[74],"and/or":[75],"dosage:":[76],"15":[77,142],"mg/day":[78,81,85,143,156,164,182],"MMI,":[79],"30":[80,155,181],"MMI":[82,144,157,183,217],"300":[84,163],"PTU.":[86,175],"The":[87,133,147,191],"type,":[88],"onset":[91,230],"assessed.":[96],"also":[98],"studied":[99],"after":[108,128],"cessation":[109],"ATD.":[113],"MEASUREMENTS:":[114],"Cutaneous":[115],"reactions,":[116],"liver":[117],"dysfunction":[118],"other":[120,188],"examined":[124],"every":[125],"2":[126],"weeks":[127],"starting":[129],"administration.":[131],"RESULTS:":[132],"overall":[134],"in":[139,152,160,179,186,211],"taking":[141,154,162],"was":[145],"low.":[146],"frequencies":[148],"cutaneous":[150,172],"reactions":[151,173],"hepatotoxicity":[159,222],"those":[161],"PTU":[165,219],"high.":[167],"Hepatotoxicity":[168,176,205],"developed":[169,177],"later":[170],"than":[171,185],"earlier":[178],"group":[184],"two":[189],"groups.":[190],"did":[196],"not":[197],"differ":[198],"between":[199],"occurred":[206],"at":[207],"higher":[209],"who":[213],"switched":[215],"from":[216],"because":[220],"former.":[225],"CONCLUSION:":[226],"Attention":[227],"times":[231],"cross-reactivity":[236],"ATDs":[238],"can":[239],"lead":[240],"safer":[242],"treatment":[243],"GD.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}